MX2021006533A - Sintesis del (s)-6-hidroxitriptofano y derivados del mismo. - Google Patents

Sintesis del (s)-6-hidroxitriptofano y derivados del mismo.

Info

Publication number
MX2021006533A
MX2021006533A MX2021006533A MX2021006533A MX2021006533A MX 2021006533 A MX2021006533 A MX 2021006533A MX 2021006533 A MX2021006533 A MX 2021006533A MX 2021006533 A MX2021006533 A MX 2021006533A MX 2021006533 A MX2021006533 A MX 2021006533A
Authority
MX
Mexico
Prior art keywords
derivatives
synthesis
synthesizing
amanitin
relates
Prior art date
Application number
MX2021006533A
Other languages
English (en)
Inventor
Werner Simon
CHRISTOPH MüLLER
Susanne Werner-Simon
Original Assignee
Heidelberg Pharma Res Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heidelberg Pharma Res Gmbh filed Critical Heidelberg Pharma Res Gmbh
Publication of MX2021006533A publication Critical patent/MX2021006533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22—Organic complexes
    • B01J31/2282—Unsaturated compounds used as ligands
    • B01J31/2295—Cyclic compounds, e.g. cyclopentadienyls
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00—Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16—Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/24—Phosphines, i.e. phosphorus bonded to only carbon atoms, or to both carbon and hydrogen atoms, including e.g. sp2-hybridised phosphorus compounds such as phosphabenzene, phosphole or anionic phospholide ligands
    • B01J31/2404—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring
    • B01J31/2409—Cyclic ligands, including e.g. non-condensed polycyclic ligands, the phosphine-P atom being a ring member or a substituent on the ring with more than one complexing phosphine-P atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00—Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/60—Reduction reactions, e.g. hydrogenation
    • B01J2231/64—Reductions in general of organic substrates, e.g. hydride reductions or hydrogenations
    • B01J2231/641—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes
    • B01J2231/645—Hydrogenation of organic substrates, i.e. H2 or H-transfer hydrogenations, e.g. Fischer-Tropsch processes of C=C or C-C triple bonds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00—Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/80—Complexes comprising metals of Group VIII as the central metal
    • B01J2531/82—Metals of the platinum group
    • B01J2531/822—Rhodium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

La presente invención se refiere a nuevos procedimientos y compuestos para sintetizar derivados de amanitina. La invención se refiere en particular a procedimientos para sintetizar derivados del (S)-hidroxitriptófano que se pueden usar como bloques de construcción en la síntesis de derivados de amanitina o conjugados amatoxina-fármaco. La invención se refiere también a compuestos intermedios de dichas rutas de síntesis para su uso en la síntesis de derivados de amanitina y conjugados amatoxina-fármaco, así como al uso de catalizadores particulares adecuados para mediar en dichas rutas de síntesis.
MX2021006533A 2018-12-11 2019-12-11 Sintesis del (s)-6-hidroxitriptofano y derivados del mismo. MX2021006533A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18211747 2018-12-11
PCT/EP2019/084544 WO2020120525A1 (en) 2018-12-11 2019-12-11 Synthesis of (s)-6-hydroxytryptophan and derivatives thereof

Publications (1)

Publication Number Publication Date
MX2021006533A true MX2021006533A (es) 2021-07-21

Family

ID=64664928

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021006533A MX2021006533A (es) 2018-12-11 2019-12-11 Sintesis del (s)-6-hidroxitriptofano y derivados del mismo.

Country Status (15)

Country Link
US (1) US20220024870A1 (es)
EP (1) EP3894390A1 (es)
JP (1) JP2022513621A (es)
KR (1) KR20210102200A (es)
CN (1) CN113166057A (es)
AR (1) AR117958A1 (es)
AU (1) AU2019396560A1 (es)
BR (1) BR112021009851A2 (es)
CA (1) CA3118031A1 (es)
CL (1) CL2021001434A1 (es)
CO (1) CO2021007237A2 (es)
IL (1) IL282566A (es)
MX (1) MX2021006533A (es)
SG (1) SG11202104455XA (es)
WO (1) WO2020120525A1 (es)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2138507A1 (en) * 2008-06-23 2009-12-30 Helmholtz-Zentrum für Infektionsforschung GmbH Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles
WO2011073173A1 (en) * 2009-12-14 2011-06-23 Helmholtz-Zentrum für Infektionsforschung GmbH Improved method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
US11066445B2 (en) * 2017-06-23 2021-07-20 Bristol-Myers Squibb Company Immunomodulators acting as antagonists of PD-1
EP3665173A1 (en) * 2017-08-07 2020-06-17 Heidelberg Pharma Research GmbH Novel method for synthesizing amanitins

Also Published As

Publication number Publication date
US20220024870A1 (en) 2022-01-27
CN113166057A (zh) 2021-07-23
IL282566A (en) 2021-06-30
BR112021009851A2 (pt) 2021-08-17
AU2019396560A1 (en) 2021-06-17
EP3894390A1 (en) 2021-10-20
CA3118031A1 (en) 2020-06-18
CL2021001434A1 (es) 2021-12-03
JP2022513621A (ja) 2022-02-09
WO2020120525A1 (en) 2020-06-18
SG11202104455XA (en) 2021-05-28
KR20210102200A (ko) 2021-08-19
AR117958A1 (es) 2021-09-08
CO2021007237A2 (es) 2021-06-21

Similar Documents

Publication Publication Date Title
NZ754051A (en) Novel antibodies and uses thereof
WO2014197871A3 (en) Antibody-drug conjugates, compositions and methods of use
PH12017500507A1 (en) Cytotoxicity-inducing therapeutic agent
MX2017008215A (es) Conjugados de farmacos proteinas de union que comprenden derivados de antraciclina.
MX2016017030A (es) Inhibidores de cinasa de interaccion con proteina cinasa activada por mitogeno (mnk) y metodos relacionados con los mismos.
NZ588884A (en) Cross-linkers and their uses
GEP20217211B (en) Substituted carbonucleoside derivatives useful as anticancer agents
MX2016016515A (es) Derivados de auristatina y conjugados de los mismos.
EA201001126A1 (ru) Пирролопиримидины и пирролопиридины
MX2020001472A (es) Nuevo metodo para sintetizar amanitinas.
IL204437A (en) History of aryl cyclic profile and their use
SV2010003463A (es) Compuestos organicos
MX2016007128A (es) Compuestos del receptor 6 de quimiocina (ccr6).
WO2018217894A8 (en) FLUORINATED MARKED HALICHONDRIN DERIVATIVES AND METHODS OF SYNTHESIS THEREOF
MX2020006185A (es) Proceso para la preparacion de derivados de quinolina.
MX2009010176A (es) Derivados de aza-adamantano 4-substituidos y metodos de uso de los mismos.
PH12017501876A1 (en) Pyridopyrimidones and their use as nmda receptor modulators
MX2019008773A (es) Derivados de caliqueamicina y conjugados anticuerpo-farmaco de los mismos.
MX2018004696A (es) Analogos de epotilona, metodos de sintesis, metodos de tratamiento y conjugados con farmacos de los mismos.
MX2021006533A (es) Sintesis del (s)-6-hidroxitriptofano y derivados del mismo.
PH12018500014A1 (en) Total synthesis of shishijimicin a and analogs thereof
PH12014501313B1 (en) Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
MX2018015269A (es) Derivados de tailanstatina a, metodos de tratamiento y metodos de sintesis de los mismos.
JO2851B1 (en) 3-benzofuranil-indole-2-one-3-substituted acetamidopiprazine derivatives, preparations thereof and therapeutic use thereof.
MA33932B1 (fr) Dérivés de 2-aldoximino-5-fluoropyrimidine